Canoe Financial LP has added 940,862 shares of $OTIS to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 09-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $OTIS.
$OTIS Hedge Fund Activity
We have seen 516 institutional investors add shares of $OTIS stock to their portfolio, and 526 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO removed 15,805,439 shares (-41.7%) from their portfolio in Q2 2025, for an estimated $1,565,054,569
- GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC removed 5,452,736 shares (-99.9%) from their portfolio in Q2 2025, for an estimated $539,929,918
- MARSHALL WACE, LLP added 2,791,765 shares (+5291.5%) to their portfolio in Q2 2025, for an estimated $276,440,570
- VANGUARD GROUP INC added 1,991,860 shares (+4.3%) to their portfolio in Q2 2025, for an estimated $197,233,977
- D. E. SHAW & CO., INC. added 1,941,378 shares (+2411.6%) to their portfolio in Q2 2025, for an estimated $192,235,249
- QUBE RESEARCH & TECHNOLOGIES LTD added 1,154,504 shares (+inf%) to their portfolio in Q2 2025, for an estimated $114,318,986
- MENORA MIVTACHIM HOLDINGS LTD. removed 1,096,496 shares (-99.7%) from their portfolio in Q2 2025, for an estimated $108,575,033
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$OTIS Congressional Stock Trading
Members of Congress have traded $OTIS stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $OTIS stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 08/04.
- REPRESENTATIVE RITCHIE TORRES has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 07/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$OTIS Analyst Ratings
Wall Street analysts have issued reports on $OTIS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 10/15/2025
- Wolfe Research issued a "Outperform" rating on 10/08/2025
- RBC Capital issued a "Outperform" rating on 07/28/2025
- Barclays issued a "Underweight" rating on 07/24/2025
To track analyst ratings and price targets for $OTIS, check out Quiver Quantitative's $OTIS forecast page.
$OTIS Price Targets
Multiple analysts have issued price targets for $OTIS recently. We have seen 8 analysts offer price targets for $OTIS in the last 6 months, with a median target of $105.0.
Here are some recent targets:
- Stephen Tusa from JP Morgan set a target price of $111.0 on 10/15/2025
- Nigel Coe from Wolfe Research set a target price of $109.0 on 10/08/2025
- Joseph O'Dea from Wells Fargo set a target price of $95.0 on 10/06/2025
- Nick Housden from RBC Capital set a target price of $105.0 on 07/28/2025
- Julian Mitchell from Barclays set a target price of $90.0 on 07/24/2025
- Nicole Deblase from Deutsche Bank set a target price of $109.0 on 07/14/2025
- Chris Snyder from Morgan Stanley set a target price of $105.0 on 07/08/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $OTIS ticker page for more data.
